BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 25811077)

  • 1. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-145 functions as tumor suppressor and targets two oncogenes, ANGPT2 and NEDD9, in renal cell carcinoma.
    Lu R; Ji Z; Li X; Zhai Q; Zhao C; Jiang Z; Zhang S; Nie L; Yu Z
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):387-97. PubMed ID: 24384875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
    Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
    Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of fructose-bisphosphate aldolase A induces progression of renal cell carcinoma.
    Huang Z; Hua Y; Tian Y; Qin C; Qian J; Bao M; Liu Y; Wang S; Cao Q; Ju X; Wang Z; Gu M
    Oncol Rep; 2018 Jun; 39(6):2996-3006. PubMed ID: 29693182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of microRNA-15a suppresses the proliferation and invasion of renal cell carcinoma via direct targeting of eIF4E.
    Li G; Chong T; Xiang X; Yang J; Li H
    Oncol Rep; 2017 Oct; 38(4):1995-2002. PubMed ID: 28849086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-206 inhibits renal cell cancer growth by targeting GAK.
    Wei C; Wang S; Ye ZQ; Chen ZQ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):852-858. PubMed ID: 27924503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma.
    Yoshino H; Enokida H; Itesako T; Tatarano S; Kinoshita T; Fuse M; Kojima S; Nakagawa M; Seki N
    J Hum Genet; 2013 Aug; 58(8):508-16. PubMed ID: 23635949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.
    Su Z; Chen D; Zhang E; Li Y; Yu Z; Shi M; Jiang Z; Ni L; Yang S; Gui Y; Ye J; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1535-43. PubMed ID: 25815776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis.
    Zhai W; Ma J; Zhu R; Xu C; Zhang J; Chen Y; Chen Z; Gong D; Zheng J; Chen C; Li S; Li B; Huang Y; Xue W; Zheng J
    Br J Cancer; 2018 Aug; 119(5):591-604. PubMed ID: 30082686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
    Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
    EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressive microRNA‑138 contributes to cell migration and invasion through its targeting of vimentin in renal cell carcinoma.
    Yamasaki T; Seki N; Yamada Y; Yoshino H; Hidaka H; Chiyomaru T; Nohata N; Kinoshita T; Nakagawa M; Enokida H
    Int J Oncol; 2012 Sep; 41(3):805-17. PubMed ID: 22766839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-204 inhibits the proliferation and invasion of renal cell carcinoma by inhibiting RAB22A expression.
    Xiong F; Liu K; Zhang F; Sha K; Wang X; Guo X; Huang N
    Oncol Rep; 2016 May; 35(5):3000-8. PubMed ID: 26883716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced downregulation of miR-30c promotes epithelial-mesenchymal transition in human renal cell carcinoma.
    Huang J; Yao X; Zhang J; Dong B; Chen Q; Xue W; Liu D; Huang Y
    Cancer Sci; 2013 Dec; 104(12):1609-17. PubMed ID: 24112779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1).
    Li Y; Quan J; Chen F; Pan X; Zhuang C; Xiong T; Zhuang C; Li J; Huang X; Ye J; Zhang F; Zhang Z; Gui Y
    Biomed Pharmacother; 2019 Mar; 111():517-526. PubMed ID: 30597305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.